Association of microRNA Expression and BRAF<sup>V600E</sup> Mutation with Recurrence of Thyroid Cancer
Many miRNAs and cancer-related mutations have been proposed as promising molecular markers of papillary thyroid carcinoma (PTC). However, there are limited data on the correlation between miRNA expression, BRAF<sup>V600E</sup> mutation, and PTC recurrence. Therefore, to evaluate the pote...
Main Authors: | Daina Pamedytyte, Vaida Simanaviciene, Dalia Dauksiene, Enrika Leipute, Aurelija Zvirbliene, Valdas Sarauskas, Albertas Dauksa, Rasa Verkauskiene, Birute Zilaitiene |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/4/625 |
Similar Items
-
BRAF<sup>V600E</sup> status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China
by: Zheng Xiangqian, et al.
Published: (2012-06-01) -
<i>Snail-1</i> Overexpression Correlates with Metastatic Phenotype in BRAF<sup>V600E</sup> Positive Papillary Thyroid Carcinoma
by: Katarzyna Wieczorek-Szukala, et al.
Published: (2020-08-01) -
BRAF<sup>V600E</sup> Induction in Thyrocytes Triggers Important Changes in the miRNAs Content and the Populations of Extracellular Vesicles Released in Thyroid Tumor Microenvironment
by: Ophélie Delcorte, et al.
Published: (2022-03-01) -
Papillary Thyroid Carcinoma Tissue miR-146b, -21, -221, -222, -181b Expression in Relation with Clinicopathological Features
by: Aistė Kondrotienė, et al.
Published: (2021-03-01) -
Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer
by: Aistė Kondrotienė, et al.
Published: (2020-09-01)